STOCK TITAN

[Form 4] CeriBell, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Ceribell, Inc. insider Raymond Woo, the company's Chief Technology Officer, exercised options under a Rule 10b5-1 plan on 09/02/2025. He acquired 20,000 shares of Common Stock by exercising stock options at a $2.24 exercise price. Following the transaction, the reporting person beneficially owns 167,704 shares of common stock and directly holds 20,000 underlying shares from the exercised option. The option granted is fully vested and exercisable and has an expiration date of 06/10/2029. The Form 4 was signed by an attorney-in-fact on 09/04/2025.

Raymond Woo, Chief Technology Officer di Ceribell, Inc. e insider della società, ha esercitato opzioni nell'ambito di un piano Rule 10b5-1 il 09/02/2025. Ha acquistato 20.000 azioni ordinarie esercitando opzioni con prezzo di esercizio pari a 2,24$. Dopo l'operazione, la persona segnalante possiede beneficiariamente 167.704 azioni ordinarie e detiene direttamente 20.000 azioni sottostanti derivate dall'opzione esercitata. L'opzione concessa è completamente maturata ed esercitabile e scade il 10/06/2029. Il Modulo 4 è stato firmato da un mandatario il 09/04/2025.

Raymond Woo, director de tecnología (CTO) de Ceribell, Inc. e insider de la compañía, ejerció opciones bajo un plan Rule 10b5-1 el 02/09/2025. Adquirió 20.000 acciones ordinarias al ejercer opciones con un precio de ejercicio de 2,24$. Tras la operación, la persona informante posee en beneficio 167.704 acciones ordinarias y tiene directamente 20.000 acciones subyacentes procedentes de la opción ejercida. La opción concedida está totalmente consolidada y es exigible, con fecha de vencimiento el 10/06/2029. El Formulario 4 fue firmado por un apoderado el 04/09/2025.

Ceribell, Inc.의 최고기술책임자(CTO)이자 내부자 Raymond Woo가 2025년 9월 2일 Rule 10b5-1 계획에 따라 스톡옵션을 행사했습니다. 그는 행사가격이 2.24달러인 스톡옵션을 행사하여 보통주 20,000주를 취득했습니다. 거래 후 보고인은 보통주 167,704주를 실질적으로 보유하고 있으며, 행사된 옵션으로 인해 직접 20,000주의 기초주식을 보유하고 있습니다. 부여된 옵션은 완전히 베스팅되어 행사 가능하며 만료일은 2029년 6월 10일입니다. Form 4는 2025년 9월 4일 대리인에 의해 서명되었습니다.

Raymond Woo, directeur technique (CTO) de Ceribell, Inc. et initié de la société, a exercé des options dans le cadre d'un plan Rule 10b5-1 le 02/09/2025. Il a acquis 20 000 actions ordinaires en exerçant des options au prix d'exercice de 2,24 $. À la suite de la transaction, la personne déclarante détient bénéficiairement 167 704 actions ordinaires et possède directement 20 000 actions sous-jacentes issues de l'option exercée. L'option accordée est entièrement acquise et exerçable et expire le 10/06/2029. Le Formulaire 4 a été signé par un mandataire le 04/09/2025.

Raymond Woo, Chief Technology Officer von Ceribell, Inc. und Insider des Unternehmens, übte am 02.09.2025 Optionen im Rahmen eines Rule 10b5-1-Plans aus. Er erwarb 20.000 Stammaktien durch Ausübung von Aktienoptionen zum Ausübungspreis von 2,24$. Nach der Transaktion besitzt die meldende Person wirtschaftlich 167.704 Stammaktien und hält direkt 20.000 zugrundeliegende Aktien aus der ausgeübten Option. Die gewährte Option ist vollständig unverfallbar und ausübbar und läuft am 10.06.2029 ab. Das Formular 4 wurde am 04.09.2025 von einem Bevollmächtigten unterzeichnet.

Positive
  • Transaction executed under a Rule 10b5-1 trading plan, which documents prearranged trading and reduces concerns about opportunistic timing
  • Insider exercised fully vested options, indicating access to previously granted compensation rather than a new grant
  • Form 4 filed promptly (transaction dated 09/02/2025, Form signed 09/04/2025), showing timely disclosure
Negative
  • None.

Insights

TL;DR: Insider exercised options for 20,000 shares at $2.24 under a 10b5-1 plan, increasing direct holdings to 167,704 shares.

The exercise indicates non-discretionary execution under a pre-established Rule 10b5-1 trading plan, which typically reduces timing risk and signaling concerns about opportunistic insider trades. The transaction involved 20,000 option shares exercised at $2.24, with the options fully vested and exercisable and expiring 06/10/2029. For investors, this is a routine insider liquidity event rather than an operational disclosure; it slightly increases the insider's direct share count but does not provide new financial results or prospects.

TL;DR: The trade followed a 10b5-1 plan and was reported promptly, consistent with standard insider reporting practices.

The filing explicitly states the exercise was effected pursuant to a Rule 10b5-1 trading plan and the Form 4 was filed with a dated signature on 09/04/2025. The reporting person is the CTO and the filing identifies direct ownership amounts after the transaction. From a governance perspective, documentation of the 10b5-1 plan and timely Form 4 disclosure align with compliance expectations for insider transactions.

Raymond Woo, Chief Technology Officer di Ceribell, Inc. e insider della società, ha esercitato opzioni nell'ambito di un piano Rule 10b5-1 il 09/02/2025. Ha acquistato 20.000 azioni ordinarie esercitando opzioni con prezzo di esercizio pari a 2,24$. Dopo l'operazione, la persona segnalante possiede beneficiariamente 167.704 azioni ordinarie e detiene direttamente 20.000 azioni sottostanti derivate dall'opzione esercitata. L'opzione concessa è completamente maturata ed esercitabile e scade il 10/06/2029. Il Modulo 4 è stato firmato da un mandatario il 09/04/2025.

Raymond Woo, director de tecnología (CTO) de Ceribell, Inc. e insider de la compañía, ejerció opciones bajo un plan Rule 10b5-1 el 02/09/2025. Adquirió 20.000 acciones ordinarias al ejercer opciones con un precio de ejercicio de 2,24$. Tras la operación, la persona informante posee en beneficio 167.704 acciones ordinarias y tiene directamente 20.000 acciones subyacentes procedentes de la opción ejercida. La opción concedida está totalmente consolidada y es exigible, con fecha de vencimiento el 10/06/2029. El Formulario 4 fue firmado por un apoderado el 04/09/2025.

Ceribell, Inc.의 최고기술책임자(CTO)이자 내부자 Raymond Woo가 2025년 9월 2일 Rule 10b5-1 계획에 따라 스톡옵션을 행사했습니다. 그는 행사가격이 2.24달러인 스톡옵션을 행사하여 보통주 20,000주를 취득했습니다. 거래 후 보고인은 보통주 167,704주를 실질적으로 보유하고 있으며, 행사된 옵션으로 인해 직접 20,000주의 기초주식을 보유하고 있습니다. 부여된 옵션은 완전히 베스팅되어 행사 가능하며 만료일은 2029년 6월 10일입니다. Form 4는 2025년 9월 4일 대리인에 의해 서명되었습니다.

Raymond Woo, directeur technique (CTO) de Ceribell, Inc. et initié de la société, a exercé des options dans le cadre d'un plan Rule 10b5-1 le 02/09/2025. Il a acquis 20 000 actions ordinaires en exerçant des options au prix d'exercice de 2,24 $. À la suite de la transaction, la personne déclarante détient bénéficiairement 167 704 actions ordinaires et possède directement 20 000 actions sous-jacentes issues de l'option exercée. L'option accordée est entièrement acquise et exerçable et expire le 10/06/2029. Le Formulaire 4 a été signé par un mandataire le 04/09/2025.

Raymond Woo, Chief Technology Officer von Ceribell, Inc. und Insider des Unternehmens, übte am 02.09.2025 Optionen im Rahmen eines Rule 10b5-1-Plans aus. Er erwarb 20.000 Stammaktien durch Ausübung von Aktienoptionen zum Ausübungspreis von 2,24$. Nach der Transaktion besitzt die meldende Person wirtschaftlich 167.704 Stammaktien und hält direkt 20.000 zugrundeliegende Aktien aus der ausgeübten Option. Die gewährte Option ist vollständig unverfallbar und ausübbar und läuft am 10.06.2029 ab. Das Formular 4 wurde am 04.09.2025 von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Woo Raymond

(Last) (First) (Middle)
C/O CERIBELL, INC.
360 N. PASTORIA AVENUE

(Street)
SUNNYVALE CA 94085

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ceribell, Inc. [ CBLL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Technology Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/02/2025 M(1) 20,000 A $2.24 167,704 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $2.24 09/02/2025 M(1) 20,000 (2) 06/10/2029 Common Stock 20,000 $0 21,634 D
Explanation of Responses:
1. The option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
2. The stock option is fully vested and currently exercisable.
/s/ Louisa Daniels, Attorney-in-Fact for Raymond Woo 09/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
CeriBell, Inc.

NASDAQ:CBLL

CBLL Rankings

CBLL Latest News

CBLL Latest SEC Filings

CBLL Stock Data

452.07M
28.88M
10.39%
84.32%
3.46%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SUNNYVALE